Li Kang Biomedical Co (ROCO:6242) Accounts Payable: NT$17.7 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6242 Li Kang Biomedical Co Ltd ROCO:6242
81 GF Score
Price NT$34.35
GF Value NT$38.61
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Li Kang Biomedical Co Accounts Payable?

Li Kang Biomedical Co ROCO:6242 +1.03% 81 Accounts Payable is NT$17.7 Mil as of Mar. 2026. GuruFocus rates ROCO:6242 with a GF Score™ of 81/100 and a GF Value™ of NT$38.61 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Li Kang Biomedical Co's Accounts Payable for the quarter that ended in Mar. 2026 was NT$17.7 Mil.

Li Kang Biomedical Co's quarterly Accounts Payable increased from Sep. 2025 (NT$16.4 Mil) to Dec. 2025 (NT$20.9 Mil) but then declined from Dec. 2025 (NT$20.9 Mil) to Mar. 2026 (NT$17.7 Mil).

Li Kang Biomedical Co's annual Accounts Payable increased from Dec. 2023 (NT$17.4 Mil) to Dec. 2024 (NT$21.9 Mil) but then declined from Dec. 2024 (NT$21.9 Mil) to Dec. 2025 (NT$20.9 Mil).

Li Kang Biomedical Co Accounts Payable Related Terms

Li Kang Biomedical Co Accounts Payable Historical Data

* Premium members only.

The historical data trend for Li Kang Biomedical Co's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Li Kang Biomedical Co Accounts Payable Chart

Li Kang Biomedical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.60 25.35 17.36 21.93 20.86

Li Kang Biomedical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.49 14.72 16.41 20.86 17.67
ROCO:6242
81GF Score
Li Kang Biomedical Co Ltd ROCO:6242
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Li Kang Biomedical Co Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of NT$17.7 Mil mean?
Li Kang Biomedical Co (ROCO:6242) has a Accounts Payable of NT$17.7 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Li Kang Biomedical Co and its competitors.
Is Li Kang Biomedical Co's Accounts Payable too high?
Li Kang Biomedical Co's current Accounts Payable is NT$17.7 Mil. Overall, Li Kang Biomedical Co has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Li Kang Biomedical Co's Accounts Payable compare to BKNG and ABNB?
Li Kang Biomedical Co's Accounts Payable of NT$17.7 Mil can be compared against companies in the Travel & Leisure industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Travel & Leisure company?
A good Accounts Payable depends on the Travel & Leisure industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Li Kang Biomedical Co and its competitors. Li Kang Biomedical Co's current Accounts Payable is NT$17.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Li Kang Biomedical Co stock overvalued right now?
Based on GuruFocus' analysis, Li Kang Biomedical Co (ROCO:6242) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$38.61, compared to a current price of NT$34.35 — trading 11% below its estimated fair value. The current Accounts Payable is NT$17.7 Mil. Li Kang Biomedical Co's overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Li Kang Biomedical Co (ROCO:6242), the current Accounts Payable is NT$17.7 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Li Kang Biomedical Co (ROCO:6242) Overvalued in 2026?

Based on GuruFocus' analysis, Li Kang Biomedical Co stock appears to be undervalued. The current stock price of NT$34.35 is trading 11% below its estimated GF Value™ of NT$38.61. GuruFocus considers Li Kang Biomedical Co to be Modestly Undervalued.

Key valuation signals for ROCO:6242:

  • Accounts Payable: NT$17.7 Mil
  • GF Value™: NT$38.61 vs. price of NT$34.35 (11% below fair value)
  • GF Score™: 81/100 with 4 warning signs

No single metric tells the full story. See the ROCO:6242 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Li Kang Biomedical Co Business Description

Address No.29, Huangong Road, Wangxingl, Yongkang District, Tainan City, TWN, 71041
Li Kang Biomedical Co Ltd is a Taiwan based company engages in tourism factory businesses, telemarketing, as well as the manufacturing and sales of cosmetics and hygienic drinks.
81GF Score

Get the complete analysis for ROCO:6242

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$34.35
Price
NT$38.61
GF Value